A detailed history of Boston Trust Walden Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Boston Trust Walden Corp holds 149,743 shares of EW stock, worth $10.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
149,743
Previous 149,703 0.03%
Holding current value
$10.1 Million
Previous $13.8 Million 28.54%
% of portfolio
0.07%
Previous 0.1%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$59.7 - $93.78 $2,388 - $3,751
40 Added 0.03%
149,743 $9.88 Million
Q4 2023

Jan 24, 2024

SELL
$61.71 - $77.76 $136,502 - $172,005
-2,212 Reduced 1.46%
149,703 $11.4 Million
Q3 2023

Oct 18, 2023

SELL
$69.28 - $93.38 $48,496 - $65,366
-700 Reduced 0.46%
151,915 $10.5 Million
Q2 2023

Jul 24, 2023

SELL
$81.41 - $94.33 $90,446 - $104,800
-1,111 Reduced 0.72%
152,615 $14.4 Million
Q1 2023

Apr 19, 2023

SELL
$74.26 - $84.51 $66,091 - $75,213
-890 Reduced 0.58%
153,726 $12.7 Million
Q4 2022

Jan 20, 2023

SELL
$68.3 - $87.44 $50,268 - $64,355
-736 Reduced 0.47%
154,616 $0
Q3 2022

Oct 19, 2022

SELL
$82.37 - $107.29 $901,127 - $1.17 Million
-10,940 Reduced 6.58%
155,352 $12.8 Million
Q2 2022

Jul 22, 2022

SELL
$86.5 - $128.27 $45,499 - $67,470
-526 Reduced 0.32%
166,292 $15.8 Million
Q1 2022

Apr 20, 2022

SELL
$101.96 - $128.34 $1.79 Million - $2.25 Million
-17,510 Reduced 9.5%
166,818 $19.6 Million
Q4 2021

Jan 21, 2022

SELL
$106.37 - $130.68 $531,850 - $653,400
-5,000 Reduced 2.64%
184,328 $23.9 Million
Q3 2021

Oct 25, 2021

BUY
$102.91 - $122.75 $84,283 - $100,532
819 Added 0.43%
189,328 $21.4 Million
Q2 2021

Jul 22, 2021

SELL
$83.84 - $104.76 $603,648 - $754,272
-7,200 Reduced 3.68%
188,509 $19.5 Million
Q1 2021

Apr 21, 2021

SELL
$78.68 - $90.67 $1.53 Million - $1.76 Million
-19,445 Reduced 9.04%
195,709 $16.4 Million
Q4 2020

Jan 15, 2021

SELL
$71.69 - $91.23 $57,352 - $72,984
-800 Reduced 0.37%
215,154 $19.6 Million
Q3 2020

Oct 14, 2020

SELL
$67.19 - $87.44 $53,886 - $70,126
-802 Reduced 0.37%
215,954 $17.2 Million
Q2 2020

Jul 23, 2020

BUY
$57.54 - $76.95 $8.18 Million - $10.9 Million
142,079 Added 190.26%
216,756 $15 Million
Q1 2020

Apr 21, 2020

SELL
$52.41 - $81.0 $407,120 - $629,208
-7,768 Reduced 9.42%
74,677 $14.1 Million
Q4 2019

Jan 10, 2020

SELL
$71.7 - $82.09 $13,694 - $15,679
-191 Reduced 0.23%
82,445 $19.2 Million
Q3 2019

Oct 21, 2019

SELL
$61.55 - $75.43 $43,085 - $52,801
-700 Reduced 0.84%
82,636 $18.2 Million
Q2 2019

Jul 25, 2019

SELL
$55.74 - $64.41 $12,875 - $14,878
-231 Reduced 0.28%
83,336 $15.4 Million
Q4 2018

Jan 17, 2019

SELL
$46.41 - $56.94 $181,741 - $222,977
-3,916 Reduced 4.48%
83,567 $12.8 Million
Q2 2018

Jul 25, 2018

SELL
$42.45 - $51.3 $26,319 - $31,806
-620 Reduced 0.7%
87,483 $12.7 Million
Q1 2018

Apr 13, 2018

SELL
$37.19 - $47.45 $193,388 - $246,740
-5,200 Reduced 5.57%
88,103 $12.3 Million
Q4 2017

Jan 29, 2018

SELL
$33.79 - $39.39 $28,620 - $33,363
-847 Reduced 0.9%
93,303 $10.5 Million
Q3 2017

Oct 13, 2017

BUY
$36.29 - $38.83 $3.42 Million - $3.66 Million
94,150
94,150 $10.3 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.